logo
UL Solutions to Attend Upcoming Investor Conferences

UL Solutions to Attend Upcoming Investor Conferences

Yahoo29-05-2025
NORTHBROOK, Ill., May 29, 2025--(BUSINESS WIRE)--UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today announced that senior management of the company will participate in the following investor conferences:
William Blair 45th Annual Growth Stock Conference, June 3
Stifel 2025 Boston Cross Sector 1x1 Conference, June 4 and
Baird 2025 Global Consumer, Technology & Services Conference, June 5.
The company's presentation at the William Blair 45th Annual Growth Stock Conference, at 3:00 p.m. EDT (2:00 p.m. CDT) on June 3, will be broadcast live. The webcast can be accessed through the UL Solutions Investor Relations website at ir.ul.com. A replay of the webcast will be available on the website for 30 days after the event. Presentation materials will also be available on the website.
About UL Solutions
A global leader in applied safety science, UL Solutions Inc. (NYSE: ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers' product innovation and business growth. The UL Mark serves as a recognized symbol of trust in our customers' products and reflects an unwavering commitment to advancing our safety mission. We help our customers innovate, launch new products and services, navigate global markets and complex supply chains, and grow sustainably and responsibly into the future. Our science is your advantage.
Source Code: ULS-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20250529368414/en/
Contacts
Investors:Dan Scott / Rodny Nacier, ICR Inc.IR@ul.com
Media:Kathy FiewegerSenior Vice President – Chief Corporate Communications OfficerKathy.Fieweger@ul.com 312-852-5156
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Viking Therapeutics stock falls 37% on high dropout rate in obesity trial
Viking Therapeutics stock falls 37% on high dropout rate in obesity trial

Yahoo

time36 minutes ago

  • Yahoo

Viking Therapeutics stock falls 37% on high dropout rate in obesity trial

-- Viking Therapeutics (NASDAQ:VKTX) stock plunged as much as 37% Tuesday after revealing results from its Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment, while Eli Lilly (NYSE:LLY) shares gained 1.5% as analysts pointed to competitive advantages. The trial demonstrated that Viking's oral tablet formulation of VK2735, a dual GLP-1 and GIP receptor agonist, met its primary endpoint with patients losing up to 12.2% of body weight after 13 weeks compared to 1.3% for placebo. Despite the weight loss efficacy, the 28% treatment discontinuation rate among patients receiving VK2735 versus 18% for placebo raised significant concerns among investors and analysts. Mizuho analyst Jared Holz highlighted competitive disadvantages compared to Eli Lilly's offerings: "Data look inferior to LLY on almost all metrics and the thing to consider here is that patients discontinued at such a high rate over 13-weeks vs. LLY in the mid 20% range --- but over 72-weeks; A much longer trial, and therefor LLY looks far better head-to-head. This probably shutters hope for VKTX a bigtime player in the oral obesity market over the near to medium term." JPMorgan (NYSE:JPM) analyst Hardik Parikh offered a more balanced view, noting, "In 13 weeks, the three highest-dosing arms of 60/90/120mg showed avg pbo-adj weight loss of ~7.5%, 10%, 11%, which we think is very strong compared with other orals in development. Tolerability overall was manageable, but it was worse than we expected based on the ph1 performance." Parikh added that while the adverse event profile wasn't as clean as in Phase 1 trials, "we still think oral vk-2735 offers strong efficacy with a manageable tolerability profile." Viking reported that 99% of gastrointestinal-related adverse events were mild or moderate. The company also highlighted an exploratory maintenance dosing arm showing weight loss could be maintained at lower doses. The major adverse events included vomiting rates of 20-35% in the three highest dose arms compared to about 10% for placebo, and nausea rates of approximately 58% for patients on treatment versus 48% for placebo. Related articles Viking Therapeutics stock falls 37% on high dropout rate in obesity trial Tesla robotaxi trial impresses, pricing power clear: William Blair Palo Alto Networks gains after strong earnings and Bank of America upgrade

Meta's First ‘Real' Smart Glasses Have One Huge Problem
Meta's First ‘Real' Smart Glasses Have One Huge Problem

Gizmodo

timean hour ago

  • Gizmodo

Meta's First ‘Real' Smart Glasses Have One Huge Problem

When Google Glass came stumbling onto the scene in 2013, people were taken aback. Not only did Google's smart glasses, with their bordering-on-novel camera, present new and somewhat icky questions about personal privacy, but they also crossed an even more controversial line: they looked really, really dorky. Fast forward more than 10 years into the future, and all of those hangups (at least on the surface) seem to be in the rearview. Take Meta, for example. Sales of Meta's Ray-Ban smart glasses have been surprisingly high, keeping even its waning Quest mixed reality headset afloat. Meta is rumored to be on the precipice of launching its first-ever pair of 'real' smart glasses, which is to say glasses with an actual display in them. And naturally, more than a decade removed from Google Glass, the rhetoric around Meta's glasses (codenamed Hypernova) couldn't be more disparate from smart glasses of yore. People are excited; they're watching; even Apple is rumored to be looking at the field as a potential new frontier. So, this is all money in the bank for Meta, right? Maybe, but I wouldn't count those shiny new metaverse dollars just yet. As promising as Meta's push into smart glasses might be, there's one quirk with Hypernova that I can't seem to get off my mind. It's not the glasses themselves, necessarily, but the rumored 'neural wristband' that reportedly comes with them. Let me backtrack for a moment for those that haven't been keeping up; as I mentioned previously, Meta's next smart glasses will most likely have a display. If they have a screen, then they're going to need a way for people to control things on said display, including 'mini apps,' which are stripped-down versions of apps that can run on glasses and are a capability rumored by Bloomberg. There are a few ways you could go about controlling a pair of smart glasses with apps, but Meta's approach is allegedly a 'neural wristband,' which is a wearable that reads the electrical signals in your arm for finger- and hand-based inputs. This is where the weirdness comes in. On one hand (or wrist, I guess), a wristband that reads the signals sent through your brain and into your hand is objectively kind of awesome. Like, damn, that's some future shit if I've ever seen it. On the other, it's a big liability at best. As useful as a wristband like that may be, asking people to strap on a wearable to use their smart glasses properly is a tall order. My guess is most people paying $800 (the rumored price of Hypernova) for a futuristic pair of smart glasses will want an all-in-one package. It's not a big deal on paper to remember to strap your wristband on, but what if it needs a charge? What if you don't like wearing stuff on your wrist or arm? Or—and this is what I think is arguably the biggest problem—what if you don't like how it looks? One of the biggest problems with Google Glass, as I mentioned before, is that you looked like you were wearing a gadget when you had it on. So much so that anyone who dared slide them onto their face was dubbed a 'glasshole.' It was Google Glass's noticeable camera module and display prism that turned it into a pariah and prevented what could have been a fruitful category of device from growing past an infancy stage. It's not all about looks, obviously—2013 was also a very different time when it came to personal privacy, a concept that has been severely eroded as the years have gone on. But I think there's a reason Meta's very much glasses-presenting Ray-Bans, which do almost everything Google Glass did and more, have caught on, and presentation is a major part of that. But hey, things are definitely different now, and maybe the same can be said for what people are willing to wear on their bodies or not. All I know is that it seems like a lot of what could make Hypernova useful or special comes down to a wearable, and while smart glasses might be a semi-proven category, wristbands are not. Google Glass might be long dead, but just because those mistakes are in the rearview doesn't mean they can't be made again.

2 Growth Stocks to Buy With $200 and Hold Forever
2 Growth Stocks to Buy With $200 and Hold Forever

Yahoo

timean hour ago

  • Yahoo

2 Growth Stocks to Buy With $200 and Hold Forever

Key Points Unity is in the middle of a turnaround, and growth is just around the corner. AMD is winning market share and building a massive artificial intelligence (AI) chip business. Both growth stocks are under $200 per share. 10 stocks we like better than Unity Software › You don't need much money at all to invest in some of the best growth stocks available. If you've got $200 and are ready to put it to work in the stock market, Unity Software (NYSE: U) and Advanced Micro Devices (NASDAQ: AMD) look like solid bets. Unity is on the cusp of a return to growth, and AMD is stealing market share from its biggest rival. 1. Unity Software: Staging a comeback Video game engine developer Unity has reached an inflection point, according to CEO Matthew Bromberg. The company's accelerated pace of development, its work to regain trust after the Runtime Fee debacle, and its artificial intelligence (AI)-powered Vector ad platform have brought the company close to a return to growth. Overall revenue was still down slightly in the second quarter, but things are moving in the right direction. Unity's Create Solutions segment, which includes its game engine, grew revenue in the second quarter, thanks to a large customer win and an increase in subscription revenue. The Grow Solutions segment, which focuses on advertising, shrank slightly. However, Unity Ad Network grew revenue by 15% compared to the first quarter, thanks to the new Vector platform, which was offset by weakness in other areas. In the third quarter, Unity expects its Grow Solutions segment to report mid-single-digit revenue growth compared to the second quarter, a sign the Vector platform is gaining traction. Create Solutions will be weaker due to the large customer win in the second quarter that won't be repeated. Overall revenue is expected between $440 million and $450 million, up from the second quarter at the midpoint. Unity may not look like much of a growth stock right now, but the company has all the pieces in place to become a long-term winner. The Unity game engine is widely used across the video game industry, and switching costs are significant. On the advertising side, the Vector platform aims to fix issues that have plagued that part of the business for years. As Unity gets back on its feet, now's a great time to buy stock. 2. AMD: A force in CPUs and AI AMD still finds itself in a second-place position behind Intel in the PC and server CPU markets, but the company has gained an incredible amount of ground thanks to good products and Intel's various issues. AMD managed a 27.3% unit share and a 41% revenue share in the server CPU market during the second quarter of 2025. Eight years ago, Intel had a near-monopoly. A similar story has played out in the PC CPU market. AMD managed a 32.2% unit share of the desktop CPU market and a 20.6% unit share of the notebook CPU market, both of which are up dramatically over the past decade. The company's Ryzen CPUs have been winning over consumers as Intel struggled with stability issues for its Raptor Lake chips and later a lackluster launch for Arrow Lake. Outside of CPUs, AMD has built a solid AI accelerator business as well. The company is still far behind market leader Nvidia, but its Instinct data center GPUs are now a multibillion-dollar annual revenue business. The company sees this as a long-term opportunity as AI chip demand continues to explode, with the potential for tens of billions of dollars in annual revenue down the road. AMD faces a few risks. First, Intel under its new CEO could become more aggressive and put pressure on AMD's CPU businesses. Second, if the AI boom starts to fizzle out, the AI accelerator business may not be as lucrative in the long run as the company is assuming. However, even with those risks, AMD is a much stronger company than it was even five years ago, and it should continue to thrive in the years ahead. Do the experts think Unity Software is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Unity Software make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,070% vs. just 184% for the S&P — that is beating the market by 885.55%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Timothy Green has positions in Intel. The Motley Fool has positions in and recommends Advanced Micro Devices, Intel, Nvidia, and Unity Software. The Motley Fool recommends the following options: short August 2025 $24 calls on Intel. The Motley Fool has a disclosure policy. 2 Growth Stocks to Buy With $200 and Hold Forever was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store